Health • May 18, 2026
New pancreatic cancer pill could reshape treatment as early trial results stun researchers
Originally published on Fox News Health
A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.
A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.
Originally published on Fox News Health.
More good news
- Amid Spokane fires, local bootmaker turns headquarters into refuge for firefighters, distributes new shoes for free
- Town’s Beloved Santa Claus Delivers a Very Special Present to Someone in Need–His Donated Kidney
- That time you learn you've been lying to yourself.
- Man recreates a 30 years photo of him and his dad, with his son